Open AccessQuality of life and Q-TWiST were not adversely affected in Ewing sarcoma patients treated with combined anlotinib, irinotecan, and vincristine
Author(s) -
Song Dong,
Kunkun Sun,
Lu Xie,
Jie Xu,
Xin Sun,
Tingting Ren,
Yi Huang,
Rongli Yang,
Xiaodong Tang,
Fan Yang,
Jin Gu,
Wei Guo
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000028078
Subject(s) - medicine , irinotecan , vincristine , sarcoma , oncology , quality of life (healthcare) , twist , chemotherapy , cancer , pathology , cyclophosphamide , colorectal cancer , geometry , mathematics , nursing